ARTICLE | Distillery Therapeutics
Gastrointestinal
March 7, 2018 7:10 PM UTC
Patient sample and mouse studies suggest inhibiting PAK1 and PAK2 could help treat colitis. In samples from patients with inflammatory bowel disease (IBD), levels of a PAK1-induced gene signature were...
BCIQ Company Profiles